Dinauer P A, Balingit A G, Rivera J E
Department of Radiology, Walter Reed Army Medical Center, Washington, District of Columbia 20307-5001, USA.
Clin Nucl Med. 1996 Mar;21(3):192-6. doi: 10.1097/00003072-199603000-00002.
Double-phase scintigraphy using Tc-99m sestamibi MIBI is the study of choice for detecting parathyroid adenoma in patients with primary hyperparathyroidism. However, before parathyroid imaging, these patients may uncommonly present with multiple osteolytic lesions and bone scan findings consistent with metastatic disease. By excluding malignancy, the diagnosis of osteitis fibrosa cystica and parathyroid adenoma may subsequently be confirmed. The authors describe the case of an elderly patient who presented with imaging findings initially masquerading as metastatic disease. When parathyroid adenoma was finally diagnosed with Tc-99m MIBI imaging, radiopharmaceutical uptake was also noted within several brown tumors, including clinically significant brown tumors of the left lower extremity, a finding that has not been previously reported.
使用锝-99m甲氧基异丁基异腈(Tc-99m sestamibi MIBI)进行的双相闪烁扫描是检测原发性甲状旁腺功能亢进患者甲状旁腺腺瘤的首选检查方法。然而,在进行甲状旁腺成像之前,这些患者可能罕见地出现多个溶骨性病变以及与转移性疾病相符的骨扫描结果。通过排除恶性肿瘤,随后可确诊纤维囊性骨炎和甲状旁腺腺瘤。作者描述了一例老年患者的病例,其最初的影像学表现伪装成转移性疾病。当最终通过Tc-99m MIBI成像诊断出甲状旁腺腺瘤时,在多个棕色瘤内也发现了放射性药物摄取,包括左下肢具有临床意义的棕色瘤,这一发现此前未见报道。